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Abstract 
 
The aim of the present study was to investigate the protective effect of Withaferin-A on red blood cell 
integrity during 7,12-dimethylbenz[a]anthracene (DMBA) induced oral carcinogenesis. The protective effect of 
Withaferin-A was assessed by measuring the status of glycoconjugates, membrane bound enzyme activity and red 
blood cell osmotic fragility. Oral squamous cell carcinoma was induced in the buccal pouch of Syrian golden 
hamsters by painting with 0.5% DMBA in liquid paraffin thrice a week for 14 weeks. The levels of glycoconjugates, 
membrane bound enzyme activity, osmotic fragility and thiobarbituric acid reactive substances (TBARS) were 
analyzed by using specific colorimetric methods. We observed 100% tumor formation in DMBA painted hamsters. 
Increase in plasma glycoconjugates at the expense of red blood cell membrane glycoconjugates levels were observed 
in DMBA painted hamsters as compared to control hamsters. Erythrocytes from DMBA painted hamsters were more 
fragile than those from control hamsters. The activity of membrane bound enzyme (Na+ K+ ATPase)  decreased 
whereas TBARS level was increased in DMBA painted hamsters as compared to control hamsters. Oral 
administration of Withaferin-A at a dose of 20mg kg-1 bw significantly prevented the tumor formation as well as 
normalized the biochemical variables in DMBA painted hamsters. Our results thus demonstrate the protective effect 
of Withaferin-A on red blood cell integrity during DMBA induced oral carcinogenesis. 
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Introduction 
 
Carcinogenesis is a multi-step process involving several mutations, each of which results in discrete 
changes in the cellular metabolism (Ranajit, 2004). Oral squamous cell carcinoma is predominantly a disease of 
human population in the fifth to eighth decades of life. The incidence and mortality rate of oral cancer vary widely 
across the world. However, the higher incidences of oral cancer are reported every year from developing countries, 
particularly from India (Moore et al., 2000). Epidemiological studies have shown that chewing of betel quid with 
tobacco is the major etiological factor of oral carcinogenesis in India (Gupta and Nandakumar; 1999).  
The importance of tumor markers for the detection of malignancies and its prognosis has prompted the  
investigation of the possible biochemical markers of several malignancies. DMBA-induced experimental oral cancer 
is the most widely-accepted experimental model for studying chemoprevention of oral cancer, since it has several 
morphological and histological similarities with human oral carcinoma (Miyata et al., 2001; Shklar, 1999).  
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Neoplastic transformation of a variety of cell types is associated with changes in the composition of 
membrane glycoproteins (Dwivedi et al., 1990). Glycoproteins are complex proteins in which carbohydrates are 
linked covalently to asparagine or serine or threonine residues of polypeptides. The cell surface glycoproteins have 
been shown to play an important role in pinocytosis, differentiation, tumorigenesis, intracellular recognition and 
adhesion, as receptors for many hormones and viruses and as mediators of immunological specificity. Tumor-
associated carbohydrate changes have also been used in the diagnosis of human cancers (Dabelsteen, 1996).  
Measurement of serum glycoconjugates is useful in the diagnosis of patients with oral pre-cancer or cancer 
(Manoharan et al, 2004).  
Sialic acid, a group of acylated neuraminic acid, plays a major role in the antigenic characterization of 
cells. They are widely distributed in nature as terminal sugars on oligosaccharides attached to protein or lipid 
moieties. Sialic acid molecules can potentially inhibit intermolecular and intercellular interaction by virtue of their 
negative charge. Serum sialic acid levels have been used as laboratory markers in cancers (Goodarzi et al, 2005; 
Sebzda et al, 2006). It has also been demonstrated that metastatic potential of tumor cells is proportional to cell 
surface sialylation (Varki, 1997). Marked elevation of serum sialic acid concentrations with various clinical stages 
of a disease has been documented in several malignancies including oral cancer (Manoharan et al., 2008 and 
Aranganathan et al., 2005). Serum fucose, a terminal pentose sugar of the glycoprotein chains, is detectable in the 
blood of both normal persons and persons with different types of malignancies. Profound studies have shown an 
increased serum fucose level in a wide spectrum of malignancies (Vasanthi et al, 1998 ; Rao et al., 1998; Escrevente 
et al., 2006). Fucose and mannose are the most essential sugars when it comes to slowing the growth of cancer cells 
(Rao et al., 1998). 
Na+/K+-ATPase is ubiquitously distributed throughout cells of higher organisms and its importance is 
highlighted by the fact it represents the only mechanism for Na+ extrusion in mammalian cells. The Na+/K+-ATPase 
(Na+/K+-pump) maintains the electro-chemical gradients of Na+ and K+ by catalyzing the transfer of three 
intracellular Na+ ions in exchange for two extracellular K+ ions per molecule of ATP hydrolyzed (Thirunavukkarasu 
and Sakthisekaran, 2003). The activities of red blood cell membrane bound enzymes are affected during elevated 
membrane lipid peroxidation and during alterations in blood red cell osmotic fragility (Rauchova et al., 1995; 
Rajalingam et al, 2008).  
Withania somnifera (Solanaceae), a shrub commonly found on the Indian subcontinent, has been used for 
centuries as a traditional medicine for various human ailments. Experimental studies have reported that Withania 
somnifera have antitumor and immunomodulatory activities (Davis and Kuttan, 2001; Davis and Kuttan, 2000). 
Withaferin-A, a highly oxygenated steroidal lactone, is the principal withanolide in Indian Withania somnifera and 
its related Solanaceae species. Diverse pharmacological activities reported for Withaferin-A includes anti-
inflammatory, antitumor and antioxidant properties (Sharada et al., 1996; Bhattacharya et al., 1997). The structure of 
Withaferin-A is given in Figure 1.  
To the best of our knowledge, we have found no scientific reports on the protective effect of Withaferin-A 
on red blood cell integrity during 7,12-dimethylbenz[a]anthracene induced hamster buccal pouch carcinogenesis.  
The present study thus investigated the protective effect of Withferin-A on red blood cell integrity during DMBA 
induced oral carcinogenesis. 
 
 
Materials and Methods 
Animals 
 
Male golden Syrian hamsters 8-10 weeks old weighing 80-120g was purchased from National Institute of 
Nutrition, Hyderabad, India and was maintained in Central Animal House, Rajah Muthaiah Medical College and 
Hospital, Annamalai University. The hamsters were housed five in a polypropylene cage and provided standard 
pellet diet and water ad libitum. The hamsters were maintained under controlled conditions of temperature and 
humidity with a 12 h light/dark cycle. The hamsters were maintained as per the principles and guidelines of the 
ethical committee for animal care of Annamalai University in accordance with Indian National Law on animal care 
and use. 
 
Chemicals 
 
 The carcinogen, DMBA, was obtained from Sigma-Aldrich Chemical Pvt. Ltd., Bangalore India. All other 
chemicals used were of analytical grade. 
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Isolation of Withaferin-A from Withania somnifera root 
 
Withaferin-A (WA) was extracted and isolated from commercially available Withania somnifera root 
powder by the method of Subramanian and Sethi (1969). The crude extract was prepared with 95% ethanol and 
further fractionation was carried out using petroleum ether, ether and chloroform, in that order. The ether and 
chloroform fractions were subjected to column chromatography (neutral alumina) and thin layer chromatography 
(silica gel). The final product, Wihaferin-A, a steroidal lactone (4β, 27 dihydroxy-1-oxo-5β, 6β, epoxy witha 2-24 
dienolide) obtained as a creamy white crystalline substance, has Rf = 0.4 and molecular weight 470. The identity of 
isolated Withaferin-A was done by Mass spectra and its identity was confirmed by comparing with the authentic 
Withaferin-A, purchased from Calbiochem, Darmstadt, Germany. The yield and purity of the isolated Withaferin-A 
was found to be 0.11% and >90% respectively. For experimental studies, the obtained Withaferin-A is first 
dissolved in a few drops of absolute ethanol followed by dilution with 30% polyethylene glycol-400 (PEG-400) in 
phosphate-buffered saline (PBS). 
 
Experimental design  
 
The experimental design (Proposal No. 357 dated.  18.10.2006)  was approved by the Annamalai 
University animal ethical committee (Register number 160/1999/CPCSFA), Annamalai University, 
Annamalainagar. A total number of 40 hamsters were randomized into four groups of 10 hamsters each. Group 1 
hamsters were served as control and were painted with liquid paraffin alone thrice a week for 14 weeks on their left 
buccal pouches. Groups 2 and 3 hamsters were painted with 0.5% DMBA in liquid paraffin thrice a week for 14 
weeks on their left buccal pouches. DMBA painting in hamster’s buccal pouches was done by using number 4 
painting brush, which leaves approximately 0.4mg DMBA on hamster buccal pouch in each application (Shklar, 
1999). Group 2 hamsters received no other treatment. Group 3 hamsters were orally administered Withaferin-A at a 
dose of 20mg/kg bw, starting one week before the exposure to the carcinogen and continued on days alternate to 
DMBA painting, until the sacrification of the hamsters. Group 4 hamsters received oral administration of 
Withaferin-A alone throughout the experimental period. The experiment was terminated at the end of 15 weeks and 
all hamsters were sacrificed by cervical dislocation. 
 
Biochemical analysis 
 
Biochemical studies were conducted on plasma and erythrocyte membrane of control and experimental 
hamsters in each group. Blood samples were collected into heparinized tubes. The plasma was separated by 
centrifugation at 3000rpm for 15 mins. After plasma separation, the erythrocyte membrane was prepared by the 
method of Dodge et al., (1968) modified by Quist (1980). Lipid peroxidation as evidenced by the formation of 
thiobarbutiric acid reactive substances (TBARS) in erythrocyte membrane was estimated by the method of Donnan 
(1950). The precipitate obtained after treating the plasma with 95% ethanol was used for the estimation of protein 
bound hexose and hexosamine. Similarly, the precipitate obtained after treating the erythrocyte membranes with 1% 
phosphotungstic acid followed by 5% TCA was used for the estimation of protein found hexose and hexosamine. 
The protein bound hexose, hexosamine, total sialic acid and fucose were estimated by the methods of Niebes , 
1972), Wagner (1979), Warren (1959) and Dische and Shettles (1948) respectively. Plasma lipid bound sialic acid 
level was determined by the method of Katopodis and Stock (1980). Osmotic fragility was determined by the 
method of Parpart et al. (1946) and mean corpuscular fragility was calculated by recording the saline concentration, 
which would have resulted in 50% haemolysis. 
 
Statistical Analysis 
 
 The data are expressed as mean ± SD. Statistical comparisons were performed by One-way analysis of 
variance (ANOVA), followed by Duncan’s Multiple Range Test (DMRT). The results were considered statistically 
significant if the p values were less than 0.05. 
 
 
Results 
 
The levels of protein bound hexose, hexosamine, total sialic acid, lipid bound sialic acid and fucose in 
plasma of control and experimental hamsters in each group is shown in Table 1. The levels of plasma protein bound  
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Table 1: Protein bound hexose, hexosamine, total sialic acid, lipid bound sialic acid and fucose in plasma of control 
and experimental hamsters in each group (n=10) 
 
Parameters 
----------------- 
Groups 
 
Protein bound 
hexose (mg/dL) 
Protein bound 
hexosamine 
(mg/dL) 
Total Sialic acid 
(mg/dL) 
Lipid bound 
sialic acid 
(mg/dL) 
Fucose (mg/dL) 
Group I 
Control 92.10 ± 8.24
a
 78.24 ± 6.10a 50.14 ± 4.10 a 14.18 ± 1.20 a 9.38 ± 0.52 a 
Group II 
DMBA 135.30± 14.68
 b
 110.82 ± 9.26 b 79.40 ± 6.28 b 32.24 ± 2.72 b 18.23 ± 1.10b 
Group III 
DMBA + 
Withaferin-A 
100.34 ± 7.65 c 85.26 ± 7.05 c 54.85 ± 5.28 c 16.25 ± 2.20 c 10.26 ± 0.92 c 
Group IV 
Withaferin-A 90.12 ± 9.30
a
 77.53 ± 7.68a 49.43 ± 3.86a 13.44 ± 0.98a 9.30 ± 0.65a 
Values are expressed as mean ± SD. 
Values not sharing a common superscript significantly differ at P<0.05 (DMRT). 
 
 
Table 2: Protein bound hexose, hexosamine, total sialic acid levels in erythrocyte membranes of control and 
experimental hamsters in each group (n=10) 
 
Parameters 
-------------------- 
Groups 
 
Protein bound hexose 
(µg/mg protein) 
Protein bound hexosamine                
(µg/mg protein) 
Total Sialic acid 
(µg/mg protein) 
Group I 
Control 132.85 ± 10.68
a
 87.42 ± 6.83a 36.56 ± 3.41 a 
GroupII 
DMBA 97.20 ± 7.87
 b
 65.27 ± 5.94 b 24.18 ± 2.62 b 
GroupIII 
DMBA + 
Withaferin-A 
122.68 ± 9.74 c 79.66 ± 7.67 c 32.67 ± 3.22 c 
GroupIV 
Withaferin-A 135.15 ± 12.62
a
 87.62 ± 6.53a 36.75 ± 3.68a 
       
      Values are expressed as mean ± SD. 
      Values not sharing a common superscript significantly differ at P<0.05 (DMRT) 
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Figure 1: Structure of Withaferin-A 
 
Table 3: TBARS content and activity of Na+-K+ ATPase, in erythrocyte membrane and Mean corpuscular fragility 
of control and experiments hamsters in each group (n=10). 
 
Parameters 
----------------- 
Groups 
 
 
 
Erythrocyte membrane TBARS (n 
moles/mg protein) 
Na+-K+ ATPase (UA/mg 
protein) 
Mean corpuscular 
fragility* 
Group I 
Control 0.34 ± 0.07
a
 1.08 ± 0.09a 
 
      0.40 ± 0.02a 
 
Group II 
DMBA 
 
1.10 ± 0.12b 
0.76 ± 0.08b 0.64 ± 0.05b 
Group III 
DMBA + 
Withaferin-A 
 
0.42 ± 0.09c 
0.97 ± 0.09c 
 
0.48 ± 0.04c 
 
Group IV 
Withaferin-A 
 
0.32 ± 0.08a 
1.05 ± 0.07a 
 
0.39 ± 0.02a 
 
 
A - µ mole of inorganic phosphorus liberated/hour. Values are expressed as mean ± SD. 
Values not sharing a common superscript significantly differ at P<0.05 (DMRT). *Concentration of NaCl 
solution (g %) at 50% hemolysis.  
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Figure 2: Osmotic fragility curve of control and experimental hamsters in each group. The degree of haemolysis 
was calculated by comparing with 0.1% NaCl solution which represented 100% lysis. 
 
 
 
hexose, hexosamine, total sialic acid, lipid bound sialic acid and fucose were significantly increased in tumor 
bearing hamsters as compared to control hamsters. Oral administration of Withaferin-A at a dose of 20 mg/kg body 
weight to DMBA painted harmsters brought back the levels to near normal range. Hamsters treated with Withaferin-
A alone showed no significant difference in protein bound hexose, hexosamine, total sialic acid, lipid bound sialic 
acid and fucose levels as compared to control hamsters. 
The levels of protein bound hexose, hexosamine, and total sialic acid, in erythrocyte membrane of control 
and experimental hamsters in each group is shown in Table 2. The levels of protein bound hexose, hexosamine, and 
total sialic acid were significantly decreased in erythrocyte membranes of tumor bearing hamsters as compared to 
control hamsters. Oral administration of Withaferin-A at a dose of 20 mg/kg body weight to DMBA painted 
harmsters brought back the status to near normal range. Hamsters treated with Withaferin-A alone showed no 
significant difference in protein bound hexose, hexosamine, and total sialic acid levels as compared to control 
hamsters. 
The levels of erythrocyte membrane TBARS,  activity of membrane bound Na+K+-ATPase and red blood 
cell mean corpuscular fragility in control and experimental hamsters in each group are shown in Table 3 . The 
activity of membrane bound Na+K+-ATPase was significantly decreased whereas TBARS levels and mean 
corpuscular fragility were increased in red blood cell of tumor bearing hamsters as compared to control hamsters. 
The activity of Na+K+-ATPase, TBARS and mean corpuscular fragility levels were brought back to near normal 
range in DMBA-painted hamsters treated with Withaferin-A. No significant difference was observed in hamsters 
treated with Withaferin-A alone and control hamsters. 
Osmotic fragility curves for control and experimental hamsters in each group are shown in Figure 2. The 
fragility curve of DMBA painted hamsters was shifted to the right for control hamsters. Treatment of DMBA 
painted hamsters with Withaferin-A shifted the curve to the left of tumor bearing hamsters. Mean corpuscular 
fragility values did not differ significantly in hamsters treated with Withaferin-A alone as compared to control 
hamsters. 
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Discussion 
 
Cell surface glycoproteins and glycolipids of tumor cells have altered carbohydrate composition that may 
contribute to aberrant cell-cell recognition, cell adhesion, antigenicity and invasiveness characteristics of malignant 
cells (Dabelsteen, 1996). Cell surface glycosyl residues play an important role in regulating cell proliferation and 
epithelial growth (Aranganathan et al., 2005). In the present study, increased levels of plasma glycoconjugates at the 
expense of erythrocyte membranes were noticed. A loss in epithelial cell surface carbohydrate during experimental 
oral carcinogenesis has been reported (Dabelsteen, 1996). The depletion of erythrocyte membrane glycoproteins 
seen in the present study may be due to increased degradation or decreased synthesis or as a result of increased 
shedding into circulation. Increase in plasma glycoconjugates levels could therefore be due to the release of 
glycoproteins from the erythrocyte membrane or tumor tissues itself.  Neoplastic transformation leads to elevated 
plasma sialic acid concentration through the shedding or secretion of sialic acid from the tumor cell surfaces (Senthil 
et al, 2007; Suresh et al, 2007). Studies have shown that malignant changes are accompanied by increased 
expression of membrane associated fucose containing macromolecules (Kim et al, 1982; Rao et al., 1998). Tumor 
itself may contribute to circulating fucose concentrations either by spontaneous release of glycoproteins as the mass 
grows or as a result of cell damage through host attack or treatment (Glick, 1978).  Oral administration of Withferin-
A to DMBA painted animals protected the integrity of red blood cell membrane by maintaining the status of 
glycoconjugates during oral carcinogenesis. 
In the present study, erythrocyte membrane (Na+/K+-ATPase) activity was decreased accompanied by 
decrease in sodium and increase in potassium levels in plasma of tumor bearing hamsters. Oxidative stress in the 
system alters the activities of membrane bound enzymes, which is assumed to be crucial for cell lysis 
(Thirunavukarasu and Sakthisekaran, 2003). It has been reported that alterations in red cell fragility can cause 
change in Na+/K+-ATPase activity (Selvendiran and Sakthisekaran, 2004). Lowered activity of erythrocyte 
membrane Na+/K+-ATPase in oral cancer bearing hamsters is probably due to increased membrane 
lipidperoxidation. Red blood cells obtained from tumor bearing hamsters were found to be more fragile than those 
obtained from control hamsters. Increased red cell osmotic fragility is probably due to their altered lipid content and 
increased oxidative stress. Our study suggests that the membrane permeability and cellular homeostasis are severely 
disturbed during DMBA-induced oral carcinogenesis. Oral administration of Withaferin-A significantly restored 
levels of membrane TBARS, activity of Na+/K+-ATPase and red cell osmotic fragility. Our results indicate that 
Withaferin-A maintained the structural integrity of the membrane and prevented the membrane abnormalities during 
oral carcinogenesis. 
 
Conclusion 
 
The present study concludes that Withaferin-A protected red blood cell integrity during DMBA induced 
oral carcinogenesis by maintaining the status of membrane glycoconjugates, Na+/K+-ATPase activity and red blood 
cell osmotic fragility.  
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